Manufacturers Life Insurance Company, The Celldex Therapeutics, Inc. Transaction History

Manufacturers Life Insurance Company, The

  • $108 Billion
  • Q3 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 105,777 shares of CLDX stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105,777
Previous 129,787 18.5%
Holding current value
$2.69 Million
Previous $4.8 Million 25.19%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$32.06 - $44.56 $769,760 - $1.07 Million
-24,010 Reduced 18.5%
105,777 $3.59 Million
Q2 2024

Aug 14, 2024
BUY
$32.76 - $42.56 $7,960 - $10,342
243 Added 0.19%
129,787 $4.8 Million
Q1 2024

May 14, 2024
BUY
$35.22 - $51.88 $3.03 Million - $4.47 Million
86,117 Added 198.3%
129,544 $5.44 Million
Q4 2023

Feb 13, 2024
SELL
$22.61 - $40.65 $144,817 - $260,363
-6,405 Reduced 12.85%
43,427 $1.72 Million
Q3 2023

Nov 15, 2023
BUY
$25.45 - $37.46 $118,749 - $174,788
4,666 Added 10.33%
49,832 $1.37 Million
Q2 2023

Aug 11, 2023
SELL
$30.29 - $38.28 $408,460 - $516,205
-13,485 Reduced 22.99%
45,166 $1.53 Million
Q1 2023

May 15, 2023
BUY
$34.78 - $47.43 $84,411 - $115,112
2,427 Added 4.14%
61,078 $2.2 Million
Q4 2022

Aug 11, 2023
BUY
$27.78 - $45.38 $116,314 - $190,006
4,187 Added 7.69%
58,651 $2.61 Million
Q4 2022

Feb 13, 2023
BUY
$27.78 - $45.38 $116,314 - $190,006
4,187 Added 7.69%
58,651 $2.61 Million
Q3 2022

Aug 11, 2023
BUY
$22.7 - $37.57 $98,313 - $162,715
4,331 Added 8.64%
54,464 $1.53 Million
Q3 2022

Nov 03, 2022
BUY
$22.7 - $37.57 $98,313 - $162,715
4,331 Added 8.64%
54,464 $1.54 Million
Q2 2022

Aug 11, 2023
SELL
$20.5 - $37.33 $274,249 - $499,400
-13,378 Reduced 21.06%
50,133 $1.35 Million
Q2 2022

Aug 15, 2022
SELL
$20.5 - $37.33 $274,249 - $499,400
-13,378 Reduced 21.06%
50,133 $1.38 Million
Q1 2022

Aug 11, 2023
BUY
$27.64 - $39.32 $67,248 - $95,665
2,433 Added 3.98%
63,511 $2.16 Million
Q1 2022

May 20, 2022
BUY
$27.64 - $39.32 $1.11 Million - $1.58 Million
40,225 Added 172.74%
63,511 $2.19 Million
Q4 2021

Feb 16, 2022
SELL
$35.68 - $56.27 $3,318 - $5,233
-93 Reduced 0.4%
23,286 $903,000
Q3 2021

Nov 12, 2021
BUY
$28.95 - $55.99 $36,013 - $69,651
1,244 Added 5.62%
23,379 $1.26 Million
Q2 2021

Aug 12, 2021
BUY
$20.71 - $35.37 $458,415 - $782,914
22,135 New
22,135 $740,000

Others Institutions Holding CLDX

# of Institutions
207
Shares Held
67.3M
Call Options Held
1.69M
Put Options Held
980K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.19B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email